Comparative Evaluation of the Evolution of Arterial and Microcirculatory Endothelial Function in Obese Patients With Type-2 Diabetes Versus Non-diabetic Obese Patients After a First Bariatric Surgery

NCT03636243 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2025-01-07

No results posted yet for this study

Summary

The weight reduction obtained after a first bariatric surgery would improve the vascular (correction of endothelial dysfunction, improvement of arterial wall compliance and evolution of the atherothrombotic process) and microcirculatory function in obese patients with type-2 diabetes.

Conditions

  • Bariatric Surgery
  • Obese
  • Type2 Diabetes

Interventions

BIOLOGICAL

Vascularly biological assessment

22.5 ml of blood will be collected at day -15, month 3 and month 12.

BIOLOGICAL

Analysis of vasomotor endothelial function

Evaluation of the peripheral endothelial function by digital tonometry using the 'EndoPATTM2000' system \[Itamar Medical Ltd., Caeserea, Israel\] before and after induction of post occlusive reactive hyperemia at day -15, month 3 and month 12.

BIOLOGICAL

Analysis of arterial compliance

Evaluation of the aortic pulse wave velocity in the aortofemoral segment or in the periphery (on the arm-ankle segment) by calculation of central aortic pressure (CAP) using the tonometric system 'Complior ™' \[Alam Medical, France\] at day -15, month 3 and month 12

BIOLOGICAL

Exploration of microcirculation

The microcirculation exploration via analysis of the curves recorded by Laser Doppler at day -15, month 3 and month 12

BIOLOGICAL

Venous Doppler Ultrasound

aneurysm screening at day -15, month 3 and month 12

BIOLOGICAL

Arterial pressure measurement

measurement of the systolic pressure at the toe using the SysToe™ device, and measurement of systolic and diastolic blood pressure using the Dinamap™ device at day -15, month 3 and month 12

BIOLOGICAL

Intima-Media Thickness measurement

Intima-Media Thickness measurement using an ultrasound machine at day -15, month 3 and month 12

BIOLOGICAL

Exploration of neuropathy

non-invasive measurement of sudomotor function by SUDOSCAN at day -15, month 3 and month 12

BEHAVIORAL

level of physical activity

pedometer collecting the number of steps during the four days before visits at day -15, month 3 and month 12

OTHER

thoracic scanner

non-injected thoracic scanner visit at month 3

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Antonia PEREZ-MARTIN, Pr · Nîmes University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-15
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03636243 on ClinicalTrials.gov